Using population-level incidence of hepatitis C virus and immigration status for data-driven screening policies: a case study in Israel

J Public Health (Oxf). 2022 Mar 7;44(1):2-9. doi: 10.1093/pubmed/fdaa215.

Abstract

Background: Most studies estimate hepatitis C virus (HCV) disease prevalence from convenience samples. Consequently, screening policies may not include those at the highest risk for a new diagnosis.

Methods: Clalit Health Services members aged 25-74 as of 31 December 2009 were included in the study. Rates of testing and new diagnoses of HCV were calculated, and potential risk groups were examined.

Results: Of the 2 029 501 included members, those aged 45-54 and immigrants had lower rates of testing (12.5% and 15.6%, respectively), higher rates of testing positive (0.8% and 1.1%, respectively), as well as the highest rates of testing positive among tested (6.1% and 6.9%, respectively).

Discussion: In this population-level study, groups more likely to test positive for HCV also had lower rates of testing. Policy makers and clinicians worldwide should consider creating screening policies using on population-based data to maximize the ability to detect and treat incident cases.

Keywords: Screening; epidemiology; migration.

MeSH terms

  • Adult
  • Aged
  • Emigration and Immigration
  • Hepacivirus*
  • Hepatitis C* / diagnosis
  • Hepatitis C* / epidemiology
  • Hepatitis C* / therapy
  • Humans
  • Incidence
  • Israel / epidemiology
  • Mass Screening
  • Middle Aged
  • Policy
  • Prevalence

Grants and funding